Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

Smith+Nephew to showcase leading shoulder technologies for joint repair and reconstruction at ICSES 2026

$SNPress releaseSep 21, 2026, 10:00 AM ETRead the release

Smith+Nephew will showcase its shoulder repair and reconstruction portfolio at the International Congress for Shoulder and Elbow Surgery (ICSES) in Vancouver from September 22-25. The Q-FIX KNOTLESS 2.8 All-Suture Anchor is launching at the conference, joining the recently acquired TENDON SEAM Rotator Cuff Repair System, which the company says showed a 2X increase in repair strength in biomechanical testing, and the REGENETEN Bioinductive Implant, which has been used in more than 250,000 procedures since its 2014 introduction. The showcase also highlights the CORI SHOULDER handheld robotics arthroplasty offering with the AETOS Shoulder System and CORIOGRAPH pre-op planning services.

Key figures

Revenue
6200000000
Employees
17000
Revenue context
2025 annual sales (cited in About section)
Regenten 12mo retear rate
8.3% vs 25.8% standard repair; relative risk 0.32 [95% CI 0.13-0.83]
Regenten procedures completed
250000
Tendon seam gap formation decrease
10X (biomechanical testing)
Tendon seam repair strength increase
2X (biomechanical cadaver testing vs traditional techniques)

AI analysis

Red flags2 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    SN: Smith+Nephew to showcase leading shoulder technologies for joint repair and reconstruction at ICSES 2026 — AI Analysis | Signal8